| Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy. | |
| | |
MedLine Citation:
|
PMID: 22452525 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Ghrelin is the only known circulating orexigenic hormone. It increases food intake by interacting with hypothalamic and brainstem circuits involved in energy balance, as well as reward-related brain areas. A heightened gut-brain ghrelin axis is an emerging feature of certain eating disorders such as anorexia nervosa and Prader-Willi syndrome. In common obesity, ghrelin levels are lowered, whereas post-meal ghrelin levels remain higher than in lean individuals. Agents that interfere with ghrelin signalling have therapeutic potential for eating disorders, including obesity. However, most of these drugs are only in the preclinical phase of development. Data obtained so far suggest that ghrelin agonists may have potential in the treatment of anorexia nervosa, while ghrelin antagonists seem promising for other eating disorders such as obesity and Prader-Willi syndrome. However, large clinical trials are needed to evaluate the efficacy and safety of these drugs. |
| | |
Authors:
|
Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan |
Related Documents
:
|
23084185 - Fronto-occipital fasciculus, corpus callosum and superior longitudinal fasciculus tract... 23051165 - Relationships between anxiety severity, diagnosis of multiple anxiety disorders, and co... 22716145 - Psychopharmacological boundaries of schizophrenia with comorbid cannabis use disorder: ... 23421525 - Aggregation of lifetime axis i psychiatric disorders through age 30: incidence, predict... 16673805 - Uncontrollable prurigo nodularis effectively treated by roxithromycin and tranilast. 11324095 - Conduct disorder in girls: a review of the literature. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: CNS drugs Volume: 26 ISSN: 1172-7047 ISO Abbreviation: CNS Drugs Publication Date: 2012 Apr |
Date Detail:
|
Created Date: 2012-03-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9431220 Medline TA: CNS Drugs Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 281-96 Citation Subset: IM |
Affiliation:
|
Utrecht Research Group Eating Disorders, Utrecht, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary ...
Next Document: The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta...